Quantitative Human SPLUNC2 (Glycosylated) Sandwich ELISA Kit

The quantitative human SPLUNC2 (glycosylated) sandwich ELISA kit is designed to detect human short palate, lung and nasal epithelium carcinoma associated protein 2 (SPLUNC2) levels. SPLUNC2 is a protein expressed in the respiratory tract, which plays a role in innate immunity. The kit is suitable for various biological samples such as tissue homogenates, serum, plasma. Its sensitivity is 0.084 ng/mL, which can accurately detect low concentrations of SPLUNC2 in the sample.

SPLUNC2

Pre-coated ELISA plate; Lyophilized standard; Biotin-labeled antibody; HRP-avidin; Various diluents; Wash buffer; TMB chromogenic substrate; Stop solution

Tissue homogenates, serum, plasma

100 μL

0.084 ng/mL

Quantitative sandwich ELISA

1 ng/mL-10 ng/mL

1 h-5 h

450 nm

Store at 2-8°C for long term storage.

Human

Short palate, lung and nasal epithelium carcinoma associated protein 2

SPLUNC2; Short palate, lung and nasal epithelium carcinoma associated protein 2; BPIFA2; PSP; BPI fold-containing family A member 2; Parotid secretory protein

124, 132

The quantitative human SPLUNC2 (glycosylated) sandwich ELISA kit is developed for the quantitative analysis of glycosylated SPLUNC2 in samples. This measurement is valuable for research on respiratory immunity. The kit also has applications in investigations of chronic lung diseases.

Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;

Serum sample: n=5, 90-105%;
Plasma sample: n=4, 80-95%;

The standard curve is for reference only, and a new standard curve should be generated for each set of samples tested.